Call Us Today:
949.200.1600

High Risk SCC

Home >Diagnosis > High Risk SCC

High-Risk-Squamous-Cell-Carcinoma-Lip-Skin-Cancer-and-Reconstructive-Surgery-Center-Orange-County

About High Risk SCC

The vast majority of cutaneous squamous cell carcinomas (SCC) have only a limited local impact on the area of involvement. However, some of these SCC’s have an increased risk of recurrence, regional lymphatic metastases, and distant spread. There are several criteria defining high risk SCC's.

 

Tumor size > 2cm has been shown to carry increased risk of regional metastases, as high as 30% in some studies. The size is not the strongest predictor of metastases given other factors.

 

Tumor thickness, however, has been shown to be a strong predictor of both recurrence and regional spread. Tumors ≤ 2mm have negligible risk, while tumors ≥ 5mm have a 12% risk of recurrence and up to 45% risk of lymph node metastases. Invasion beyond subcutaneous tissues, for example, into lip muscle or parotid are independent high risk factors.

 

Perineural invasion is present in 5-10% of cutaneous SCC. The size of the involved nerve is a significant predictor of recurrence and death. Involved nerves ≤ 0.1mm in diameter have been shown to have a 9% risk of recurrence. While involved nerves > 0.1mm have a 50% risk of recurrence and 32% risk of death as shown by one study. Another predictor of high risk perineural invasion is neuropathic symptoms of large named nerves. This can be determined even without a biopsy by simply asking the patient.

 

Several other features are associated with high risk behavior – lymphovascular invasion and desmoplastic growth. Infiltrative features specifically has been shown to have up to 23% risk of lymph node metastases and 27% risk of recurrence. More specifically, certain histologic features are ominous – small tumor nests, infiltrative strands, and single cell infiltration. Gross behavioral features such as recurrence or satellite lesions are well known signs of aggressive tumor behavior. One often cited feature of high risk - histologic differentiation - is actually a weak predictor with conflicting evidence on both sides.

 

There are certain histologic types of cutaneous carcinomas that are high risk. Spindle cell carcinomas and adenosquamous cell carcinomas have high risk of regional and distant metastases. Microcystic adnexal carcinomas have a higher risk of recurrence.

 

Skin-Cancer-and-Reconstructive-Surgery-Center-SCARS-Newport-Beach-SRT-Dermatologist-SCC-Squamous-Cell-CarcinomaHost factors must not be overlooked such as chronic lymphocytic leukemia and its immunosuppression. Organ transplant recipients are also well-known victims of aggressive SCC behavior. However, it has been the older immunosuppressants such as cyclosporine causing higher rate of skin cancers. The newer drugs such as sirolimus (Rapamune) cause significantly fewer carcinomas.

 

Understanding what factors to consider in identifying high risk SCC of the face is the first step. Identifying those factors prior to treatment is the critical. That will be covered in upcoming articles.

Related Articles

Sentinel Lymph Node Biopsy for Cutaneous SCC
HISTORY A 58-year-old kidney transplant recipient presented with a 6-month history of squamous cell carcinoma of the left scalp. This large lesion was adjacent to the scar of a previous carcinoma excision in 2014. Patient is on sirolimus for his kidney transplant performed in 1984. He has had multiple BCCs and SCCs of scalp, back,…
Read More
Lethal Squamous Cell Carcinoma of the Forearm in a Lung Transplant Recipient
HISTORY A 71-year-old lung transplant recipient presented with a recurrence of left dorsal forearm and wrist Squamous Cell Carcinoma (SCC) after Mohs excision in 2016 performed elsewhere. The patient underwent Mohs excision with clear margins and additional deeper wide local resection with no carcinoma identified. Patient was referred for radiation oncology evaluation, but he was…
Read More
recurrent-bowens-disease-squamous-cell-carcinoma-topical-chemotherapy
Recurrent Bowen’s Disease of Temple
HISTORY 63-year-old man presents with 9-month history of Bowen’s disease of right anterior and posterior sideburn biopsied on 08-20-18. History of previous Mohs excision of Bowen’s disease of the same area in February 2016. Patient has a history of multiple basal cell carcinomas, squamous cell carcinomas, and melanoma. DISCUSSION Management of this lesion is best…
Read More
cystic-squamous-cell-carcinoma-of-forearm-keratoacanthoma-dermatopathology
Cystic Squamous Cell Carcinoma of Forearm Skin
HISTORY 74-year-old man presents with 3-month history of painful lesion of the right forearm.  Biopsy found cystic squamous cell carcinoma with deep margins involved. Wide local excision was performed achieving clear margins. DISCUSSION Cystic degeneration within squamous cell carcinoma of the skin is not considered an especially malignant finding. These histologic findings may represent changes…
Read More
anticoagulant-use-in-cutaneous-surgery-scalp-squamous-cell-carcinoma-Mohs-and-reconstruction
Anticoagulant Use in Cutaneous Surgery
HISTORY 87-year-old man with atrial fibrillation presented with squamous cell carcinoma in situ of scalp and forehead. Patient was treated with Mohs and reconstruction on 7-3-18. Incisional hematomas appeared 2.5 weeks post Mohs and treated with I&D. Patient continued warfarin and baby aspirin throughout treatments. DISCUSSION Anticoagulant use in Facial and Dermatologic Surgeries has become…
Read More
Recurrent-SCC-nose-rhinectcomy-mapping-biopsy-SCARS-center-Mohs-excision-infiltrative-squamous-cell
Recurrent SCC of Nasal Tip
HISTORY 71-year-old man presents with recurrence of SCC of nose following Mohs excision on 2-9-17. Partial rhinectomy was performed with incomplete Mohs excision leaving residual positive margins due to patient’s comfort.  Two additional excisions of involved margins were done under anesthesia achieving clear margins. First stage reconstruction was performed on 4-11-18. DISCUSSION Management of a…
Read More

STAY UP TO DATE

Receive research updates, inspiring stories, healthy living tips and more.

Something went wrong. Please check your entries and try again.

FOLLOW US

ELEVATING THE STANDARDS OF SKIN CANCER MANAGEMENT.

© 2018 SCARS Management Services. All rights reserved.